Tablet-Based Intervention for Reducing Children's Preoperative Anxiety: A Pilot Study

Cheryl H T Chow1, Ryan J Van Lieshout, Louis A Schmidt

  • 1Departments of *Psychology, Neuroscience & Behaviour, †Psychiatry and Behavioural Neurosciences, ‡Anesthesia, McMaster University, Hamilton, ON, Canada.

Insights

This pilot study found that the Story-Telling Medicine (STM) tablet application is a feasible and acceptable way to reduce children's preoperative anxiety. STM significantly lowered anxiety scores in children undergoing surgery compared to usual care.

Area of Science:

  • Pediatric Surgery
  • Child Psychology
  • Health Technology

Background:

  • Preoperative anxiety is a common issue in children undergoing surgery.
  • Effective interventions are needed to manage this anxiety.
  • Tablet-based applications offer a novel approach to patient care.

Purpose of the Study:

  • To assess the feasibility and acceptability of the Story-Telling Medicine (STM) application.
  • To evaluate the effectiveness of STM in reducing preoperative anxiety in children.
  • To compare STM combined with usual care (UC) against UC alone.

Main Methods:

  • A pilot study involving 100 children (aged 7-13) undergoing outpatient surgery.
  • Three waves of study: Waves 1 & 2 focused on feasibility, Wave 3 on acceptability and efficacy.
  • Wave 3 randomly assigned 40 children to STM+UC or UC, measuring anxiety via CPMAS at multiple time points.

Main Results:

  • Feasibility of recruitment and data collection was confirmed, with protocol modifications addressing attrition.
  • Children receiving STM+UC showed significantly greater reductions in preoperative anxiety (CPMAS scores) compared to the UC group.
  • Statistical significance was achieved (p = .015) with a notable confidence interval.

Conclusions:

  • Story-Telling Medicine (STM) is a feasible and acceptable intervention for reducing pediatric preoperative anxiety.
  • The findings support further investigation of STM in a larger randomized controlled trial.
  • STM shows promise as a tool in busy pediatric operative settings.
Abstract

Related Concept Videos

Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
2.8K
Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
13.7K
The Placebo Effect01:54

The Placebo Effect

The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.9K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
423
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
384